BCLSI
Bain Capital Life Sciences Investors’s Nuvalent NUVL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $110M | Hold |
1,447,267
| – | – | 13.82% | 3 |
|
|
2025
Q1 | $103M | Hold |
1,447,267
| – | – | 15.19% | 2 |
|
|
2024
Q4 | $113M | Sell |
1,447,267
-1,250,000
| -46% | -$97.9M | 13.33% | 2 |
|
|
2024
Q3 | $276M | Hold |
2,697,267
| – | – | 28.71% | 1 |
|
|
2024
Q2 | $205M | Hold |
2,697,267
| – | – | 22.46% | 1 |
|
|
2024
Q1 | $203M | Sell |
2,697,267
-880,000
| -25% | -$66.1M | 16.28% | 2 |
|
|
2023
Q4 | $263M | Hold |
3,577,267
| – | – | 25.23% | 1 |
|
|
2023
Q3 | $164M | Hold |
3,577,267
| – | – | 18.39% | 1 |
|
|
2023
Q2 | $151M | Hold |
3,577,267
| – | – | 15.54% | 1 |
|
|
2023
Q1 | $93.3M | Hold |
3,577,267
| – | – | 11.66% | 2 |
|
|
2022
Q4 | $107M | Buy |
3,577,267
+149,253
| +4% | +$4.44M | 11.9% | 2 |
|
|
2022
Q3 | $66.6M | Hold |
3,428,014
| – | – | 7.95% | 2 |
|
|
2022
Q2 | $46.5M | Hold |
3,428,014
| – | – | 5.45% | 6 |
|
|
2022
Q1 | $47.6M | Hold |
3,428,014
| – | – | 4.62% | 6 |
|
|
2021
Q4 | $65.3M | Hold |
3,428,014
| – | – | 5.18% | 6 |
|
|
2021
Q3 | $77.3M | Buy |
+3,428,014
| New | +$77.3M | 4.8% | 7 |
|